Keyword: Drug and Chemical Associated Technologies Association (DCAT)
Markets & Companies
11.09.2024
-
Driven by increased demand in biologic-based drugs, biologic drug substance manufacturing continues to be an active area of investment by contract development and...
Markets & Companies
26.10.2022
-
The European Commission proposed last month an emergency intervention in Europe’s energy markets to address recent dramatic price rises as the EU faces the effects of a...
Markets & Companies
20.04.2022
-
Biomanufacturing for both traditional biologics and new modalities, such as cell and gene therapies, continues to be an active area of investment for CDMOs/CMOS. Some of...
Chemistry & Life Sciences
23.11.2020
-
Sean Diver, president of DCAT speaks about the pharmaceutical industry’s role during the Covid-19 pandemic, trends in drug manufacturing, and key issues for the EU...
News
06.11.2020
-
On November 1, 2020, Sean Diver took the reins as President of the Drug, Chemical & Associated Technologies Association (DCAT).
Strategy & Management
14.09.2020
-
DCAT Value Chain Insights rounds up recent expansion activity for highly potent drug substances and drug products.
Markets & Companies
23.12.2019
- DCAT Week, held again on March 23-26, 2020, in New York City, is a premier business development event for companies engaged in pharmaceutical development and manufacturing...
Markets & Companies
19.08.2019
- Mergers and acquisitions (M&A) have played a pivotal role in the evolution of the contract development and manufacturing (CDMO) industry. However, after an especially active year...
